thymidine has been researched along with g(m2) ganglioside in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dellheden, B; Fredman, P; Hedberg, KM; Wikstrand, CJ | 1 |
1 other study(ies) available for thymidine and g(m2) ganglioside
| Article | Year |
|---|---|
Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.
Topics: Antibodies, Monoclonal; Cell Division; Central Nervous System Neoplasms; Drug Screening Assays, Antitumor; G(M2) Ganglioside; Gangliosides; Glioma; Humans; Necrosis; Thymidine; Tumor Cells, Cultured | 2000 |